Foresite Capital Fund V, L.P.
Related Filers (21)
- Foresite Capital Management V, LLC (22)
- Foresite Capital Opportunity Management V, LLC (14)
- Tananbaum James B. (14)
- Foresite Capital Opportunity Fund V, L.P. (14)
- PARDES BIOSCIENCES, INC. (9)
- Theseus Pharmaceuticals, Inc. (8)
- Foresite Capital Management IV, LLC (7)
- Foresite Capital Fund IV, L.P. (7)
- Kinnate Biopharma Inc. (7)
- Gemini Therapeutics, Inc. /DE (3)
- FS Development Holdings, LLC (3)
- FS Development Holdings II, LLC (3)
- Cullinan Oncology, Inc. (2)
- Foresite Capital Management III, LLC (2)
- Aclaris Therapeutics, Inc. (2)
- Foresite Capital Fund III, L.P. (2)
- Population Health Investment Co., Inc. (2)
- Compass Therapeutics, Inc. (2)
- Lifesci Acquisition II Corp. (1)
- LifeSci Holdings LLC (1)
- CG Oncology, Inc. (1)
- Show More ...
Other (3)
D/A
Thursday, 2/25/2021
Exempt (Private) Offering
D/A
Friday, 3/20/2020
Exempt (Private) Offering
D
Friday, 11/22/2019
Exempt (Private) Offering
Ownership (38)
SC 13G
Monday, 2/5/2024
CG Oncology, Inc.: Major Shareholders
SC 13D/A
Friday, 11/24/2023
Theseus Pharmaceuticals, Inc.: Major Shareholders
SC 13D/A
Friday, 11/17/2023
Kinnate Biopharma Inc.: Major Shareholders
SC 13D/A
Tuesday, 11/14/2023
Kinnate Biopharma Inc.: Major Shareholders
4
Thursday, 8/31/2023
PARDES BIOSCIENCES, INC.: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/19/2023
Theseus Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Wednesday, 7/19/2023
Theseus Pharmaceuticals, Inc.: Major Shareholders
4
Wednesday, 5/10/2023
Kinnate Biopharma Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 4/6/2023
PARDES BIOSCIENCES, INC.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/22/2023
Kinnate Biopharma Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Monday, 2/13/2023
Compass Therapeutics, Inc.: Major Shareholders
4
Tuesday, 1/3/2023
Theseus Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Tuesday, 1/3/2023
Theseus Pharmaceuticals, Inc.: Major Shareholders
4
Monday, 12/5/2022
PARDES BIOSCIENCES, INC.: Statement of changes in beneficial ownership of securities
SC 13D/A
Monday, 6/13/2022
Theseus Pharmaceuticals, Inc.: Major Shareholders
3
Monday, 6/13/2022
Theseus Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
4/A
Friday, 6/10/2022
PARDES BIOSCIENCES, INC.: Statement of changes in beneficial ownership of securities
SC 13G/A
Friday, 2/11/2022
Population Health Investment Co., Inc.: Major Shareholders
SC 13G/A
Friday, 2/11/2022
Cullinan Oncology, Inc.: Major Shareholders
SC 13G/A
Friday, 2/11/2022
LifeSci Holdings LLC: Major Shareholders
4/A
Thursday, 12/30/2021
PARDES BIOSCIENCES, INC.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/28/2021
PARDES BIOSCIENCES, INC.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/23/2021
PARDES BIOSCIENCES, INC.: Statement of changes in beneficial ownership of securities
SC 13G
Friday, 11/12/2021
Compass Therapeutics, Inc.: Major Shareholders
4
Wednesday, 11/3/2021
Aclaris Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13D
Monday, 10/18/2021
Theseus Pharmaceuticals, Inc.: Major Shareholders
4
Tuesday, 2/23/2021
FS Development Corp. II: Statement of changes in beneficial ownership of securities
3
Tuesday, 2/16/2021
FS Development Corp. II: Initial statement of beneficial ownership of securities
3
Wednesday, 2/10/2021
Aclaris Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 2/9/2021
Gemini Therapeutics, Inc. /DE: Statement of changes in beneficial ownership of securities
SC 13G
Friday, 1/15/2021
Cullinan Management, Inc.: Major Shareholders
4
Wednesday, 12/9/2020
Kinnate Biopharma Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 12/4/2020
Kinnate Biopharma Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 12/3/2020
Kinnate Biopharma Inc.: Initial statement of beneficial ownership of securities
SC 13G
Wednesday, 11/25/2020
Lifesci Acquisition II Corp.: Major Shareholders
SC 13G
Wednesday, 11/25/2020
Population Health Investment Co., Inc.: Major Shareholders
4
Monday, 10/19/2020
FS Development Corp.: Statement of changes in beneficial ownership of securities
3/A
Wednesday, 8/19/2020
FS Development Corp.: Initial statement of beneficial ownership of securities